Mutational spectrum of cystic fibrosis in the Lebanese population-Reference-Cited by-同舟云学术

Mutational spectrum of cystic fibrosis in the Lebanese population

Published:2010-12 Issue:6 Volume:9 Page:406-410
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Farra Chantal,Menassa Rita,Awwad Johnny,Morel Yves,Salameh Pascale,Yazbeck Nadine,Majdalani Marianne,Wakim Rima,Yunis Khalid,Mroueh Salman,Cabet Faiza

Funder

Lebanese National Council for Scientific Research (LCNRS)

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference30 articles.

1. Identification of novel mutations in Arabs with cystic fibrosis and their impact on the cystic fibrosis transmembrane regulator mutation detection rate in Arab populations;Kambouris;Eur J Pediatr,2000

2. Cystic fibrosis in Lebanon: distribution of CFTR mutations among Arab communities;Desgeorges;Hum Genet,1997

3. Novel and characteristic CFTR mutations in Saudi Arab children with severe cystic fibrosis;El-Harith;J Med Genet,1997

4. Cystic fibrosis: a new mutation in the Lebanese population;Farra;J Cyst Fibros,2008

5. Cystic fibrosis foundation patient registry;FitzSimmons,1994

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of elexacaftor–tezacaftor–ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trial;The Lancet Respiratory Medicine;2024-08

2. Diagnosis of cystic fibrosis: a high heterogeneity of symptoms and genotypes in a Brazil population;BMC Pediatrics;2024-07-01

3. Distribution of pathogenic variants in the CFTR gene in a representative cohort of people with cystic fibrosis in the Kingdom of Bahrain;Molecular Genetics and Genomics;2024-05-14

4. Cystic fibrosis in Iceland and the high prevalence of the N1303K variant;Pediatric Pulmonology;2024-04-17

5. Elexacaftor-Tezacaftor-Ivacaftor Improves Clinical Outcomes in Individuals with CF Encoding N1303K CFTR;2024